Aspectos clínicos y diagnósticos de la diabetes infantil

EMC - Pediatría - Tập 46 - Trang 1-20 - 2011
N. Bouhours-Nouet1, R. Coutant1
1Pôle enfant, Service d'endocrinologie et de diabétologie pédiatriques, Centre hospitalier universitaire d'Angers, 4, rue Larrey, 49933 Angers cedex 9, France

Tài liệu tham khảo

2009, Diagnosis and classification of diabetes mellitus, Diabetes Care, 32, S62 Charkaluk, 2002, Incidence data of childhood-onset type 1 diabetes in France during 1988-1997: the case for a shift toward younger age at onset, Pediatr. Res., 52, 859 Barat, 2008, The growing incidence of type 1 diabetes in children: the 17-year French experience in Aquitaine, Diabetes Metab., 34, 601, 10.1016/j.diabet.2008.06.002 Patterson, 2009, Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study, Lancet, 373, 2027, 10.1016/S0140-6736(09)60568-7 Atkinson, 2001, Type 1 diabetes: new perspectives on disease pathogenesis and treatment, Lancet, 358, 221, 10.1016/S0140-6736(01)05415-0 Eisenbarth, 2002, Type 1 diabetes mellitus, 1485 Achenbach, 2005, Natural history of type 1 diabetes, Diabetes, 54, S25, 10.2337/diabetes.54.suppl_2.S25 Daneman, 2006, Type 1 Diabetes, Lancet, 367, 847, 10.1016/S0140-6736(06)68341-4 2000, The Eurodiab Substudy 2 Study Group. Infections and vaccinations as risk factors for childhood type 1 (insulin-dependent) diabetes mellitus: a multicenter case-control investigation, Diabetologia, 43, 47, 10.1007/s001250050006 Ziegler, 2003, Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies, JAMA, 290, 1721, 10.1001/jama.290.13.1721 Norris, 2003, Timing of initial cereal exposure in infancy and risk of islet autoimmunity, JAMA, 290, 1713, 10.1001/jama.290.13.1713 Hviid, 2004, Childhood vaccination and type 1 diabetes, N. Engl. J. Med., 350, 1398, 10.1056/NEJMoa032665 Oresic, 2008, Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes, J. Exp. Med., 205, 2975, 10.1084/jem.20081800 Eisenbarth, 1994, Pathogenesis of insulin-dependent (type 1) diabetes mellitus, 216 Aly, 2006, Extreme genetic risk for type 1 diabetes, Proc. Natl. Acad. Sci. USA, 103, 14074, 10.1073/pnas.0606349103 Nejentsev, 2007, Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-A et HLA-B, Nature, 450, 887, 10.1038/nature06406 Concannon, 2009, Genetics of type 1A diabetes, N. Engl. J. Med., 360, 1646, 10.1056/NEJMra0808284 Nepom, 1998, Molecular basis for HLA-DQ associations with IDDM, Diabetes, 47, 1177, 10.2337/diab.47.8.1177 Baisch, 1990, Analysis of HLA DQ genotypes and susceptibility in insulin-dependent diabetes mellitus, N. Engl. J. Med., 322, 1836, 10.1056/NEJM199006283222602 Nepom, 1990, A unified hypothesis for the complex genetics of HLA associations with IDDM, Diabetes, 39, 1153, 10.2337/diab.39.10.1153 Nistico, 1996, The CTLA4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes, Hum. Mol. Genet., 5, 1075, 10.1093/hmg/5.7.1075 Bennett, 1995, Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin minisatellite locus, Nat. Genet., 9, 284, 10.1038/ng0395-284 Marron, 1997, Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphims in multiple ethnic groups, Hum. Mol. Genet., 6, 1275, 10.1093/hmg/6.8.1275 Todd, 1996, Panning for gold: genome-wide scanning for linkage in type 1 diabetes, Hum. Mol. Genet., 5, 1443, 10.1093/hmg/5.Supplement_1.1443 Concannon, 1998, A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus, Nat. Genet., 19, 292, 10.1038/985 Davies, 1994, A genome wide search for human type 1 diabetes susceptibility genes, Nature, 371, 161, 10.1038/371130a0 Burton, 2007, Association scan of 14,500 non synonymous SNPs in four diseases identifies autoimmunity variants, Nat. Genet., 39, 1329, 10.1038/ng.2007.17 Todd, 2007, Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes, Nat. Genet., 39, 857, 10.1038/ng2068 Cooper, 2008, Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci, Nat. Genet., 40, 1399, 10.1038/ng.249 Grant, 2009, Follow up analysis of genome-wide association data identifies novel loci for type 1 diabetes, Diabetes, 58, 290, 10.2337/db08-1022 Boitard, 1995, Les mécanismes cellulaires du diabète insulinodépendant, Méd Ther, 1, 125 Roep, 1995, T-cell reactivity to beta-cell membrane antigens associated with beta-cell destruction in IDDM, Diabetes, 44, 278, 10.2337/diab.44.3.278 Atkinson, 1994, Cellular immunity to a determinant common to glutamic acid decarboxylase and Coxsackie virus in insulin dependent diabetes, J. Clin. Invest., 94, 2125, 10.1172/JCI117567 Van Endert, 2006, HLA class I epitope discovery in type 1 diabetes, Ann. N. Y. Acad. Sci., 1079, 190, 10.1196/annals.1375.030 Verge, 1996, Prediction of type I diabetes in first degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies, Diabetes, 45, 926, 10.2337/diab.45.7.926 Bingley, 1994, Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives, Diabetes, 43, 1304, 10.2337/diab.43.11.1304 Thivolet, 1991, Autoantibodies and genetic factors associated with the development of type I (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients, Diabetologia, 34, 186, 10.1007/BF00418274 Riley, 1990, A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes, N. Engl. J. Med., 323, 1167, 10.1056/NEJM199010253231704 Thivolet, 1992, Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals, Diabetologia, 35, 570, 10.1007/BF00400486 Atkinson, 1993, Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes, J. Clin. Invest., 91, 350, 10.1172/JCI116192 Baekkeskov, 1990, Identification of 64 kd autoantigen in insulin dependent diabetes as the GABA synthesizing enzyme glutamic acid decarboxylase, Nature, 347, 151, 10.1038/347151a0 Myers, 1995, Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase, Diabetes, 44, 1290, 10.2337/diab.44.11.1290 Gianani, 1995, ICA 512 autoantibody radioassay, Diabetes, 44, 1340, 10.2337/diab.44.11.1340 Kupila, 2001, Feasability of genetic and immunological prediction of type 1 diabetes in a population-based birth cohort, Diabetologia, 44, 290, 10.1007/s001250051616 Kulmala, 1998, Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The childhood Diabetes in Finland Study Group, J. Clin. Invest., 101, 327, 10.1172/JCI119879 Barker, 2004, Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY), J. Clin. Endocrinol. Metab., 89, 3896, 10.1210/jc.2003-031887 Ziegler, 1999, Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes, Diabetes, 48, 460, 10.2337/diabetes.48.3.460 Sabbah, 2000, Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes, Diabetes Care, 23, 1326, 10.2337/diacare.23.9.1326 Mallone, 2007, CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes, Diabetes, 56, 613, 10.2337/db06-1419 Ferré, 1990, Homéostasie glucidique, 30 Karjalainen, 1989, A comparison of childhood and adult type 1 diabetes mellitus, N. Engl. J. Med., 320, 881, 10.1056/NEJM198904063201401 Chaïeb, 1989, Données cliniques et biologiques caractérisant en France le diabète insulinoprive de l'enfant au moment de son diagnostic, Arch. Fr. Pediatr., 46, 107 Roche, 2005, Clinical presentation of type 1 diabetes, Pediatr. Diabetes, 6, 75, 10.1111/j.1399-543X.2005.00110.x Nathan, 2008, A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values, Diabetes Care, 31, 1473, 10.2337/dc08-0545 Bougnères, 1990, Acidocétose diabétique, 166 Glaser, 2001, Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics, N. Engl. J. Med., 344, 264, 10.1056/NEJM200101253440404 Vanelli, 1999, Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices, Diabetes Care, 22, 7, 10.2337/diacare.22.1.7 Komulainen, 1999, Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes, Diabetes Care, 22, 1950, 10.2337/diacare.22.12.1950 Taboulet, 2007, Correlation between urine ketones (acetoacetate) and capillary blood ketones (3-beta-hydroxybutyrate) in hyperglycaemic patients, Diabetes Metab., 33, 135, 10.1016/j.diabet.2006.11.006 Adrogué, 1982, Plasma acid-base patterns in diabetic ketoacidosis, N. Engl. J. Med., 307, 1603, 10.1056/NEJM198212233072603 Kulmala, 2000, Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children, Diabetes, 49, 48, 10.2337/diabetes.49.1.48 2002, Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus, N. Engl. J. Med., 346, 1685, 10.1056/NEJMoa012350 2004, European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes, Lancet, 363, 925, 10.1016/S0140-6736(04)15786-3 Skyler, 2005, Effects of oral insulin in relatives of patients with type 1 diabetes. The Diabetes Prevention Trial-Type 1, Diabetes Care, 28, 1068, 10.2337/diacare.28.5.1068 Nanto-Salanen, 2008, Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial, Lancet, 372, 1746, 10.1016/S0140-6736(08)61309-4 Lucidarme, 1998, Appraisal and implications of predictive testing for insulin-dependent diabetes mellitus, Diabetes Metab., 24, 550 Notkins, 2001, Autoimmune type 1 diabetes: resolved and unresolved issues, J. Clin. Invest., 108, 1247, 10.1172/JCI200114257 Vardi, 1991, Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet-cell antibody positive relatives of type 1 (insulin-dependent) diabetic patient, Diabetologia, 34, 93, 10.1007/BF00500379 Mrena, 2006, Models for predicting type 1 diabetes in siblings of affected children, Diabetes Care, 29, 662, 10.2337/diacare.29.03.06.dc05-0774 LaGasse, 2002, Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies, Diabetes Care, 25, 505, 10.2337/diacare.25.3.505 Scofield, 2004, Autoantibodies as predictors of disease, Lancet, 363, 1544, 10.1016/S0140-6736(04)16154-0 Rosilio, 1998, Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes, Diabetes Care, 21, 1146, 10.2337/diacare.21.7.1146 2001, Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT), J. Pediatr., 139, 804, 10.1067/mpd.2001.118887 Mortensen, 1997, Comparaison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidore Study Group on Childhood Diabetes, Diabetes Care, 20, 714, 10.2337/diacare.20.5.714 Mortensen, 1998, Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidore Study Group on Childhood Diabetes, Diabet. Med., 15, 752, 10.1002/(SICI)1096-9136(199809)15:9<752::AID-DIA678>3.0.CO;2-W Lievre, 2005, Cross-sectional study of care, socio-economic status and complications in young french patients with type 1 diabetes mellitus, Diabetes Metab., 31, 41, 10.1016/S1262-3636(07)70165-9 Morris, 1997, Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus, Lancet, 350, 1505, 10.1016/S0140-6736(97)06234-X Littlefield, 1992, Relationship of self-efficacy and binging to adherence to diabetes regimen among adolescent, Diabetes Care, 15, 90, 10.2337/diacare.15.1.90 Hood, 2009, Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis, Pediatrics, 124, 1171, 10.1542/peds.2009-0207 Patterson, 2007, Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989, Diabetologia, 50, 2439, 10.1007/s00125-007-0824-8 Morris, 1997, Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus, Lancet, 350, 1505, 10.1016/S0140-6736(97)06234-X Clements, 1978, Fatal diabetic ketoacidosis: major cause and approaches to their prevention, Diabetes Care, 1, 314, 10.2337/diacare.1.5.314 Cryer, 1994, Hypoglycemia, Diabetes Care, 17, 734, 10.2337/diacare.17.7.734 Cryer, 2004, Diverse causes of hypoglycemia-associated autonomic failure in diabetes, N. Engl. J. Med., 350, 2272, 10.1056/NEJMra031354 1994, Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial, J. Pediatr., 125, 177, 10.1016/S0022-3476(94)70190-3 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med., 329, 977, 10.1056/NEJM199309303291401 Ahern, 2002, Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups, Pediatr. Diabetes, 3, 10, 10.1034/j.1399-5448.2002.30103.x Nimri, 2006, Insulin pump therapy in youth with type 1 diabetes mellitus: a retrospective paired study, Pediatrics, 117, 2126, 10.1542/peds.2005-2621 Fox, 2005, A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes, Diabetes Care, 28, 1277, 10.2337/diacare.28.6.1277 Weintrob, 2003, Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial, Pediatrics, 112, 559, 10.1542/peds.112.3.559 Bougnères, 1990, Diabète insulino-dépendant aux âges pré-scolaires, 231 1997, Hypoglycemia in the Diabetes Control and Complications Trial, Diabetes, 46, 271, 10.2337/diab.46.2.271 Hershey, 2005, Frequency and timing of severe hypoglycemia affects spatial memory in children with type 1 diabetes, Diabetes Care, 28, 2372, 10.2337/diacare.28.10.2372 Gaudieri, 2008, Cognitive function in children with type 1 diabetes: a meta-analysis, Diabetes Care, 31, 1892, 10.2337/dc07-2132 Lévy-Marchal, 2000, Risk factors for microalbuminuria in children and adolescents with type 1 diabetes, J. Pediatr. Endocrinol. Metab., 13, 613, 10.1515/JPEM.2000.13.6.613 Holl, 1999, Urinary excretion of albumin in adolescents with type 1 diabetes, Diabetes Care, 22, 1555, 10.2337/diacare.22.9.1555 Donaghue, 2009, ISPAD clinical practice guidelines 2009 compendium. Microvascular and macrovascular complications associated with diabetes in children and adolescents, Pediatr. Diabetes, 10, 195, 10.1111/j.1399-5448.2009.00576.x Guide médecin de l'HAS sur le diabète de type 1 chez l'enfant et l'adolescent. Juillet 2007. http://www.has-sante.fr/portail/jcms/c_419643/ald-n8. Perkins, 2003, Regression of microalbuminuria in type 1 diabetes, N. Engl. J. Med., 348, 2285, 10.1056/NEJMoa021835 Massin, 2007, Prevalence of diabetic retinopathy in children and adolescents with type 1 diabetes attending summer camps in France, Diabetes Metab., 33, 284, 10.1016/j.diabet.2007.03.004 Flechtner, 2007, Diabète néonatal: une maladie aux multiples mécanismes, Arch. Pediatr., 14, 1356, 10.1016/j.arcped.2007.08.010 Gloyn, 2004, Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes, N. Engl. J. Med., 350, 1838, 10.1056/NEJMoa032922 Metz, 2002, Neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases, J. Pediatr., 141, 483, 10.1067/mpd.2002.127089 Vaxillaire, 2004, Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of french patients, Diabetes, 53, 2719, 10.2337/diabetes.53.10.2719 Sagen, 2004, Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2. Patient characteristics and initial response to sulfonylurea therapy, Diabetes, 53, 2713, 10.2337/diabetes.53.10.2713 Gloyn, 2005, Relapsing diabetes can result from moderately activating mutations in KCNJ11, Hum. Mol. Genet., 14, 925, 10.1093/hmg/ddi086 Babenko, 2006, Activating mutations in the ABCC8 gene in neonatal diabetes mellitus, N. Engl. J. Med., 355, 456, 10.1056/NEJMoa055068 Vaxillaire, 2007, New ABCC8 mutations in relapsing neonatal diabetes and clinical features, Diabetes, 56, 1737, 10.2337/db06-1540 Edghill, 2008, Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood, Diabetes, 57, 1034, 10.2337/db07-1405 Polak, 2008, Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group, Diabetes, 57, 1115, 10.2337/db07-1358 Njolstad, 2001, Neonatal diabetes mellitus due to complete glucokinase deficiency, N. Engl. J. Med., 344, 1588, 10.1056/NEJM200105243442104 Eisenbarth, 2004, Autoimmune polyendocrine syndromes, N. Engl. J. Med., 350, 2068, 10.1056/NEJMra030158 Maassen, 2004, Mitochondrial diabetes. Molecular mechanisms and clinical presentation, Diabetes, 53, S103, 10.2337/diabetes.53.2007.S103 Gerbitz, 1996, Mitochondria and diabetes, Diabetes, 45, 113, 10.2337/diab.45.2.113 Barrett, 1995, Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome, Lancet, 346, 1458, 10.1016/S0140-6736(95)92473-6 Barrett, 2001, Mitochondrial diabetes, DIDMOAD, and other inherited diabetes syndromes, Best Pract Res Clin Endocrinol Metab, 15, 325, 10.1053/beem.2001.0149 Inoue, 1998, A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrom), Nat. Genet., 20, 143, 10.1038/2441 El-Shanti, 2000, Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q, Am. J. Hum. Genet., 66, 1229, 10.1086/302858 Kanki, 2009, Mitochondrial abnormalities drive cell death in Wolfram syndrome 2, Cell Res., 19, 922, 10.1038/cr.2009.94 Fajans, 2001, Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young, N. Engl. J. Med., 345, 971, 10.1056/NEJMra002168 Vaxillaire, 2008, Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes, Endocr. Rev., 29, 254, 10.1210/er.2007-0024 Reznik, 2004, Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY) 3 families, J. Clin. Endocrinol. Metab., 89, 1476, 10.1210/jc.2003-031552 Fagot-Campagna, 2004, Diabète de type 2 de l'enfant, Méd Clin Endocrinol Diabète, 9, 39 Mayer-Davis, 2009, The many faces of diabetes in American youth: type 1 and type 2 diabetes in five race and ethnic populations: the SEARCH for Diabetes in Youth Study, Diabetes Care, 32, S99, 10.2337/dc09-S201 Feltbower, 2003, Type 2 and other forms of diabetes in 0–30 year olds: a hospital based study in Leeds, UK, Arch. Dis. Child., 88, 676, 10.1136/adc.88.8.676 Rami, 2003, Austrian Diabetes Incidence Study group. Type 2 diabetes mellitus is rare but not absent in children under 15 years of age in Austria, Eur. J. Pediatr., 162, 850, 10.1007/s00431-003-1323-7 Druet, 2006, Insulin resistance and the metabolic syndrome in obese French children, Clin. Endocrinol. (Oxf.), 64, 672, 10.1111/j.1365-2265.2006.02526.x Kempf, 2008, Impaired glucose regulation and type 2 diabetes in children and adolescents, Diabetes Metab. Res. Rev., 24, 427, 10.1002/dmrr.869 2000, Type 2 diabetes in children and adolescents, Diabetes Care, 23, 381, 10.2337/diacare.23.3.381 Sobngwi, 2008, Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-saharan africans, JAMA, 299, 2770, 10.1001/jama.299.23.2770 Gonthier, 2003 Robert, 2006 Bougnères, 1994 Bougnères, 2006 Kahn, 2004 Grimaldi, 2005 Guide médecin de l'HAS sur le diabète de type 1 chez l'enfant et l'adolescent. http://www.has-sante.fr/portail/jcms/c_419643/ald-n8-prise-en-charge-du-diabete-de-type-1-chez-l-enfant-et-l-adolescent. Guide patient de l'HAS sur le diabète de type 1 chez l'enfant et l'adolescent. http://www.has-sante.fr/portail/jcms/c_419643/ald-n8-prise-en-charge-du-diabete-de-type-1-chez-l-enfant-et-l-adolescent. Association française d'aide aux jeunes diabétiques. www.ajd-educ.org. Association française des diabétiques. www.afd.asso.fr. International Society for Pediatric and Adolescent Diabetes. www.ispad.org. www.cepidc.vesinet.inserm.fr.